Warren Buffett fit · Wonderful businesses at fair prices
Is Regeneron Pharmaceuticals, Inc. (REGN) a Warren Buffett Stock?
Partial Buffett fit - meets 6/9 key criteria, but with reservations.
64/100
CMixed signals
6/9 criteria passed
+10 sector-quality lift. Top-quintile within its sector on 5 of 5 quality metrics. Raw pillar score 54 → lifted to 64 before grade derivation.
Warren Buffett's Criteria, Applied to REGN
ROIC ≥ 15%
key8.5%
Gross margin ≥ 40%
key84.5%
Owner earnings yield ≥ 5%
key5.7%
5y profitable
keyYes
Net Debt / EBITDA ≤ 3
-0.0x
Revenue CAGR ≥ 8%
-2.8%
EPS CAGR ≥ 8%
-13.3%
FCF / Net income ≥ 0.8
0.9x
Debt / Equity ≤ 1
0.1x
How REGN Scores on Other Strategies
Live Financial Snapshot
Market cap
$68.79B
P/E (TTM)
16.4x
ROIC (TTM)
8.53%
Gross margin
84.55%
Other Warren Buffett fit reports
Frequently Asked Questions
What is REGN's Warren Buffett fit score?
REGN scores 64/100 on our Warren Buffett fit engine - grade C. Partial Buffett fit - meets 6/9 key criteria, but with reservations.
Does Warren Buffett actually own REGN?
Our score is computed from financial fundamentals against Warren Buffett's published criteria. We don't claim that Warren Buffett personally owns or recommends REGN.
How often is this score updated?
REGN's Warren Buffett fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Warren Buffett personally owns or recommends REGN.